Johnson & Johnson to buy Shockwave Medical for $12.5B, expanding heart device portfolio. Deal, J&J s largest since Abiomed acquisition, includes shockwave tech for heart diseases. Deal expected to close mid-2024.
Drug major Johnson & Johnson (JNJ) announced Friday its agreement to acquire Shockwave Medical, Inc. (SWAV) for $335.00 per share in cash. The enterprise value of the deal is around $13.